US2009054255A1PendingUtilityA1
Microfluidic devices and methods
Est. expiryJul 1, 2024(expired)· nominal 20-yr term from priority
B01J 2219/00612B01J 2219/00637C40B 60/12B01J 2219/00608B01J 2219/00635B01L 3/502715G01N 21/78G01N 2021/054B01J 2219/0061G01N 2021/7763B01J 2219/00315B01J 2219/00479G01N 2021/058G01N 33/6845G01N 2021/7773Y02A50/30G01N 2021/0346B01J 2219/00621B01J 2219/00626G01N 21/05G01N 33/581G01N 2021/825G01N 33/6803B01J 2219/00617G01N 21/82B01J 2219/00531G01N 33/54366B01L 2300/0654
50
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Contemplated microfluidic devices and methods are drawn to protein arrays in which distinct and detergent-containing antigen preparations are deposited onto an optical contrast layer in a non-specific and non-covalent manner. Detection of binding a is carried out using a dye that precipitates or agglomerates to so form a visually detectable signal at a dynamic range of at least three orders of magnitude.
Claims
exact text as granted — not AI-modified1 . A method of performing an analytic test, comprising:
providing a carrier having a surface comprising an optical contrast layer; wherein a plurality of detergent-containing non-purified distinct antigen preparations are non-covalently and non-specifically coupled to the optical contrast layer at respective predetermined locations to form an antigen array having a density of at least 10 distinct antigen preparations per cm 2 ; wherein the optical contrast layer has a thickness and composition sufficient to prevent confluence of the antigen preparations when the distinct antigen preparations are deposited onto the optical contrast layer; contacting the antigen array with a solution comprising an antibody under conditions to allow binding of the antibody to an antigen of at least one of the antigen preparations; and detecting binding of the antibody using a visually detectable, and precipitating or agglomerating dye.
2 . The method of claim 1 wherein the contrast layer and the antigen preparations have a composition such that the step of detecting binding of the antibody allows detection over a dynamic range of at least three orders of magnitude.
3 . The method of claim 1 wherein the array comprises at least two distinct antigens from the same pathogen.
4 . The method of claim 3 wherein the at least two distinct antigens have known quantified and known relative reactivities with respect to sera of a population infected with the pathogen.
5 . The method of claim 1 wherein the carrier is enclosed in a chamber of a housing, wherein the chamber has a volume of 1 μl and 50 μl.
6 . The method of claim 5 wherein the chamber has a plurality of cavities sized and positioned to allow resonance mixing of a fluid that is in contact with the array.
7 . The method of claim 6 further comprising a step of mixing the fluid at between 3 and 4 kHz.
8 . The method of claim 1 wherein the dye is selected from the group consisting of 3-amino-9-ethylcarbazole, 5-bromo-4-chloro-3-indolylphosphate, 3-3′-diaminobenzidine tetrachloride, 3,3′,5,5′-tetramethylbenzidine, and a colloidal metal.
9 . The method of claim 1 wherein the step of detecting is performed using a scanner or CCD detector.
10 . The method of claim 1 wherein the step of detecting is performed from opposite sides of the optical contrast layer.
11 . A microfluidic device, comprising:
an enclosed reaction volume formed at least in part by a carrier material to which an optical contrast layer is coupled, wherein the optical contrast layer is disposed within the reaction volume and opposite to a cavity layer within the reaction volume; wherein a plurality of distinct antigens is non-covalently and non-specifically coupled to the optical contrast layer in predetermined positions; wherein the cavity layer has plurality of cavities that are sized and dimensioned to allow trapping of air in the plurality of cavities; wherein at least one of the number and size of the cavities is selected such that hybridization of an antibody to at least one of the plurality of antigens is substantially complete within less than 60 minutes upon mixing; and wherein the carrier material and optical contrast layer are configured to allow quantitative detection of a visually detectable, and precipitating or agglomerating dye.
12 . The microfluidic device of claim 11 wherein the optical contrast layer comprises nitrocellulose.
13 . The microfluidic device of claim 11 wherein the carrier material comprises at least one of glass and a transparent synthetic polymer.
14 . The microfluidic device of claim 11 wherein the cavities in the cavity layer are circular cavities arranged at regular intervals in x- and y-coordinate.
15 . The microfluidic device of claim 11 wherein a ratio between a number of the antigens to a number of cavities is at least 3:1, and wherein a ratio between an area of an antigen and a cavity diameter is at least 1:3.
16 . The microfluidic device of claim 11 wherein the reaction volume is between 1 μl and 50 μl.
17 . The microfluidic device of claim 11 wherein the carrier material and the optical contrast layer are configured to allow quantitative detection over a dynamic range of at least three orders of magnitude.
18 . The microfluidic device of claim 11 wherein the plurality of distinct antigens are non-purified and further comprise a detergent.
19 . The microfluidic device of claim 11 wherein the dye is selected from the group consisting of 3-amino-9-ethylcarbazole, 5-bromo-4-chloro-3-indolylphosphate, 3-3′-diaminobenzidine tetrachloride, 3,3′,5,5′-tetramethylbenzidine, and a colloidal metal.
20 . The microfluidic device of claim 11 wherein the carrier material and the optical contrast layer are configured to allow optical detection from opposite sides of the optical contrast layer.Join the waitlist — get patent alerts
Track US2009054255A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.